Atai Life Sciences Operating Expenses 2020-2024 | ATAI
Atai Life Sciences operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| Atai Life Sciences Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2023 | $126 |
| 2022 | $145 |
| 2021 | $156 |
| 2020 | $104 |
| 2019 | $18 |
| Atai Life Sciences Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $23 |
| 2024-06-30 | $26 |
| 2024-03-31 | $24 |
| 2023-12-31 | $34 |
| 2023-09-30 | $27 |
| 2023-06-30 | $32 |
| 2023-03-31 | $33 |
| 2022-12-31 | $38 |
| 2022-09-30 | $38 |
| 2022-06-30 | $36 |
| 2022-03-31 | $33 |
| 2021-12-31 | $45 |
| 2021-09-30 | $34 |
| 2021-06-30 | $61 |
| 2021-03-31 | $16 |
| 2020-12-31 | $87 |
| 2020-09-30 | $7 |
| 2020-06-30 | $6 |
| 2020-03-31 | $4 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.290B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.458B | 11.77 |
| Quest Diagnostics (DGX) | United States | $17.988B | 18.23 |
| DaVita (DVA) | United States | $12.872B | 16.65 |
| Encompass Health (EHC) | United States | $9.984B | 23.54 |
| Chemed (CHE) | United States | $8.238B | 25.32 |
| Elanco Animal Health (ELAN) | United States | $6.580B | 15.66 |
| RadNet (RDNT) | United States | $5.911B | 130.90 |
| Option Care Health (OPCH) | United States | $3.713B | 17.60 |
| Amedisys (AMED) | United States | $2.948B | 20.98 |
| LifeStance Health (LFST) | United States | $2.770B | 0.00 |
| Astrana Health (ASTH) | United States | $2.302B | 31.49 |
| Addus HomeCare (ADUS) | United States | $2.180B | 25.57 |
| U.S Physical Therapy (USPH) | United States | $1.368B | 35.96 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.121B | 0.00 |
| Pennant (PNTG) | United States | $1.093B | 44.18 |
| Daxor (DXR) | United States | $0.043B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.008B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |